Investor Cvf, Llc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Cvf, Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-02-12 13G/A NARI / Inari Medical, Inc. 2,914,246 0
2024-11-07 13G/A NARI / Inari Medical, Inc. 2,591,665 2,914,246
2024-02-14 13G GUTS / Fractyl Health, Inc. 4,673,870
2023-02-10 13G/A UTRS / Minerva Surgical, Inc. 2,259,690 2,259,685
2023-02-10 13G/A NARI / Inari Medical, Inc. 2,591,665 2,591,665
2022-02-10 13G/A NARI / Inari Medical, Inc. 2,691,665 2,591,665
2022-02-10 13G UTRS / Minerva Surgical, Inc. 2,259,690
2021-02-05 13G/A NARI / Inari Medical, Inc. 2,941,665 2,691,665
2020-11-20 13G NARI / Inari Medical, Inc. 2,941,665
2018-02-09 13G/A DARE / Daré Bioscience, Inc. 2,601,387 260,137
2017-02-10 13G/A DARE / Daré Bioscience, Inc. 2,599,920 2,601,387
2016-02-11 13G/A GNCA / Genocea Biosciences Inc 1,226,320 1,226,320
2016-02-11 13G/A DARE / Daré Bioscience, Inc. 2,599,920 2,599,920
2016-02-10 13G/A DARE / Daré Bioscience, Inc. 2,599,920
2016-02-10 13G/A GNCA / Genocea Biosciences Inc 1,226,320
2015-02-17 13G GNCA / Genocea Biosciences Inc 1,218,740
2015-02-17 13G DARE / Daré Bioscience, Inc. 2,259,244